- Recommendation ID
- DG36/1
- Question
Further primary research is recommended on the clinical effectiveness of using ELISA tests for therapeutic monitoring of TNF‑alpha inhibitors in people with rheumatoid arthritis.
- Any explanatory notes
(if applicable)
Source guidance details
- Comes from guidance
- Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis
- Number
- DG36
- Date issued
- July 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/07/2019 |